Fully human glyco-optimized recombinant FSH (follitropin epsilon) – a randomized, comparator-controlled phase II clinical trial

Georg Griesinger*, Bruno Dietrich, Lars Stöckl, Kelvin Eckert, Steffen Goletz, Andreas Tandler-Schneider

*Corresponding author for this work
2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Fully human glyco-optimized recombinant FSH (follitropin epsilon) – a randomized, comparator-controlled phase II clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences